Tetomilast Terminated Phase 2 Trials for Ulcerative Colitis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00317356A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis